$NBIO Wide Open, paper thin. Lets get this train started. Solid company, low burn rate, 2 drugs in clinical trials. Its go time. Easy run to $5 in the months ahead. SOLID DD, Check out this presentation!!!! http://www.nascentbiotech.com/wp-content/uploads/2016/12/NBIO-Investor-Presentation-11.12.2016.pdf